Stanley Szefler, MD

Grants

Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE) (2017)

Colorado Comprehensive School-centered Asthma Program (AsthmaCOMP) (2018)

Reducing Asthma Attacks in Disadvantaged School Children with Asthma (2020)

Research Interests for Patients

Dr. Szefler's major contributions have been directed toward the appropriate use of long-term control therapy in asthma, including the recognition of variability in response to asthma therapy. He has identified biomarkers and asthma characteristics that can be used to predict and thus individualize asthma therapy. Dr. Szefler is the former Director of the Pediatric Asthma Research Program and former Research Medical Director in the Breathing Institute of the Pediatric Pulmonary Section at Children's Hospital Colorado. He is also Professor Emeritus of Pediatrics at the University of Colorado Anschutz School of Medicine. He is also a former member of the Expert Panel for the National Heart, Lung, and Blood Institute's National Asthma Education and Prevention Program on "Guidelines for the Diagnosis and Management of Asthma" and a former member of the Global Initiative for Asthma Science Committee. From 1997 through 2018 he served as Deputy Editor for the Journal of Allergy and Clinical Immunology. He has published more than 650 scientific articles and co-edited books on severe asthma, childhood asthma and pediatric allergy and immunology and personalized medicine. He is the former Multiple-Principal Investigator for the Denver site of the NHLBI PrecISE Network that is focused on identifying new treatment for severe and exacerbation prone asthma. He is the former Multiple-Principal Investigator for the NHLBI DECIPHeR Alliance that is designed to reduce health disparities by improving asthma control in disadvantaged children. For the past twenty years, he has directed a school-based asthma program for the Denver Public School system funded by the Colorado Department of Public Health and Environment Colorado Cancer, Cardiovascular and Pulmonary Disease Program. This program seeks to define the prevalence and severity of asthma, identify those most significantly affected, and to direct those children to state of the art asthma care. The program was awarded a 7-year NHLBI UG3 dissemination and implementation grant (DECIPHeR) in 2020 to assess the feasibility of extending the school-centered asthma program to 5 regional hubs in Colorado that will be completed in 2027.